Exacerbation of chronic epidural abscess following a fludarabine-based preparative regimen.
Miura
Yuji
Y
Kami
Masahiro
M
Kusumi
Eiji
E
Murashige
Naoko
N
Masuoka
Kazuhiro
K
Yoshimura
Madoka
M
Tachibana
Shintaro
S
Taniguchi
Shuichi
S
D000081:Acetamides / Q000008:administration & dosage*; D000741:Anemia, Aplastic / Q000150:complications / Q000628:therapy; D000890:Anti-Infective Agents / Q000008:administration & dosage*; D020802:Epidural Abscess / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D006086:Graft vs Host Disease / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D019653:Myeloablative Agonists / Q000008:administration & dosage*; D023303:Oxazolidinones / Q000008:administration & dosage*; D011859:Radiography; D013203:Staphylococcal Infections / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000382:microbiology; D033581:Stem Cell Transplantation; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D000081:Acetamides; D000890:Anti-Infective Agents; D019653:Myeloablative Agonists; D023303:Oxazolidinones; D014740:Vidarabine; D000069349:Linezolid; C024352:fludarabine